Literature DB >> 33800029

The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model.

Alonso Jerez-Morales1,2, José S Merino3, Sindy T Díaz-Castillo2, Carlos T Smith1, Jorge Fuentealba4, Humberto Bernasconi2, Gerson Echeverría5, Apolinaria García-Cancino1.   

Abstract

Indoxyl sulfate (IS) is involved in the progression of chronic kidney disease (CKD) and in its cardiovascular complications. One of the approaches proposed to decrease IS is the administration of synbiotics. This work aimed to search for a probiotic strain capable to decrease serum IS levels and mix it with two prebiotics (inulin and fructooligosaccharide (FOS)) to produce a putative synbiotic and test it in a rat CKD model. Two groups of Sprague-Dawley rats were nephrectomized. One group (Lac) received the mixture for 16 weeks in drinking water and the other no (Nef). A control group (C) included sham-nephrectomized rats. Serum creatinine and IS concentrations were measured using high-performance liquid chromatography with diode array detector (HPLC-DAD). Optical microscopy and two-photon excitation microscopy was used to study kidney and heart samples. The Lac group, which received the synbiotic, reduced IS by 0.8% while the Nef group increased it by 38.8%. Histological analysis of kidneys showed that the Lac group increased fibrotic areas by 12% and the Nef group did it by 25%. The synbiotic did not reduce cardiac fibrosis. Therefore, the putative synbiotic showed that function reducing IS and the progression of CKD in a rat model, but no heart protection was observed.

Entities:  

Keywords:  CKD; CVD; indoxyl sulfate; renal fibrosis; synbiotic

Year:  2021        PMID: 33800029      PMCID: PMC7999732          DOI: 10.3390/toxins13030192

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  35 in total

1.  A differential medium for lactic acid-producing bacteria in a mixed culture.

Authors:  H M Lee; Y Lee
Journal:  Lett Appl Microbiol       Date:  2008-04-25       Impact factor: 2.858

Review 2.  Alterations of intestinal barrier and microbiota in chronic kidney disease.

Authors:  Alice Sabatino; Giuseppe Regolisti; Irene Brusasco; Aderville Cabassi; Santo Morabito; Enrico Fiaccadori
Journal:  Nephrol Dial Transplant       Date:  2014-09-04       Impact factor: 5.992

3.  The influence of mutant lactobacilli on serum creatinine and urea nitrogen concentrations and renal pathology in 5/6 nephrectomized rats.

Authors:  Fang Wang; Yun-Sheng Jiang; Fang Liu
Journal:  Ren Fail       Date:  2016-09-08       Impact factor: 2.606

4.  Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function.

Authors:  Keerati Wanchai; Sakawdaurn Yasom; Wannipa Tunapong; Titikorn Chunchai; Sathima Eaimworawuthikul; Parameth Thiennimitr; Chaiyavat Chaiyasut; Anchalee Pongchaidecha; Varanuj Chatsudthipong; Siriporn Chattipakorn; Nipon Chattipakorn; Anusorn Lungkaphin
Journal:  Clin Sci (Lond)       Date:  2018-07-31       Impact factor: 6.124

Review 5.  The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.

Authors:  Hans-Joachim Anders; Kirstin Andersen; Bärbel Stecher
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

Review 6.  Gut microbiota, hypertension and chronic kidney disease: Recent advances.

Authors:  Antonio Sircana; Franco De Michieli; Renato Parente; Luciana Framarin; Nicola Leone; Mara Berrutti; Elena Paschetta; Daria Bongiovanni; Giovanni Musso
Journal:  Pharmacol Res       Date:  2018-01-31       Impact factor: 7.658

7.  Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats.

Authors:  Maimaiti Yisireyili; Hidehisa Shimizu; Shinichi Saito; Atsushi Enomoto; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  Life Sci       Date:  2013-05-21       Impact factor: 5.037

8.  Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model.

Authors:  Ya-Jane Lee; Kuan-Yi Li; Pin-Jhu Wang; Hsiao-Wen Huang; Ming-Ju Chen
Journal:  J Food Drug Anal       Date:  2019-10-17       Impact factor: 6.079

9.  Dysbiosis of the gut microbiota in disease.

Authors:  Simon Carding; Kristin Verbeke; Daniel T Vipond; Bernard M Corfe; Lauren J Owen
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

10.  Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).

Authors:  Maria Teresa Rocchetti; Carmela Cosola; Ighli di Bari; Stefania Magnani; Vanessa Galleggiante; Letizia Scandiffio; Giuseppe Dalfino; Giuseppe Stefano Netti; Mauro Atti; Roberto Corciulo; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2020-03-10       Impact factor: 4.546

View more
  5 in total

1.  Lactiplantibacillus plantarum P9 improved gut microbial metabolites and alleviated inflammatory response in pesticide exposure cohorts.

Authors:  Wenjun Liu; Changkun Li; Bohai Li; Qingxiang Shang; Zhe Han; Yuan Zhang; Xiufang Liu; Hui Fan; Jiachao Zhang; Yongfu Chen; Heping Zhang
Journal:  iScience       Date:  2022-05-26

2.  Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1➔3)-β-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34.

Authors:  Somkanya Tungsanga; Wimonrat Panpetch; Thansita Bhunyakarnjanarat; Kanyarat Udompornpitak; Pisut Katavetin; Wiwat Chancharoenthana; Piraya Chatthanathon; Naraporn Somboonna; Kriang Tungsanga; Somying Tumwasorn; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

Review 3.  Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation.

Authors:  Avra Melina Madella; Jeroen Van Bergenhenegouwen; Johan Garssen; Rosalinde Masereeuw; Saskia Adriana Overbeek
Journal:  Toxins (Basel)       Date:  2022-09-18       Impact factor: 5.075

4.  Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs.

Authors:  Yu-Chin Huang; Tzu-Chun Tsai; Chia-Hsin Chang; Kuo-Ting Chang; Pin-Hao Ko; Liang-Chuan Lai
Journal:  Toxins (Basel)       Date:  2021-12-07       Impact factor: 4.546

5.  New Strategies for the Reduction of Uremic Toxins: How Much More We Know.

Authors:  Maria Teresa Rocchetti
Journal:  Toxins (Basel)       Date:  2021-11-24       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.